Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Olfactory dysfunction in multiple sclerosis.
Intermittent Atrioventricular Block following Fingolimod Initiation.
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab.
17β-trenbolone, an anabolic-androgenic steroid as well as an environmental hormone, contributes to neurodegeneration.
Breastfeeding is associated with lower risk for multiple sclerosis.
[Posture disorders in patients with multiple sclerosis.]
Id1 Expression Promotes T Regulatory Cell Differentiation by Facilitating TCR Costimulation.
Is natalizumab overshooting its rebound?
A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.
Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon Beta treatment.
No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis.
A Patient with Leiden V Mutation, Multiple Sclerosis, Psoriasis, and Sicca Syndrome: Could Celecoxib and Fingolimod Adversely Affect the Heart?
Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability.
Our history
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living.
[Gluten-related disorders and demyelinating diseases.]
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy.
Comparing routine neurorehabilitation program with trunk exercises based on Bobath concept in multiple sclerosis: Pilot study.
Effects of sleep and wake on oligodendrocytes and their precursors.
Alemtuzumab 3-year data show durable effect on MS disability
In vivo vs. ex vivo Magnetic Resonance Imaging In Mice.
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.

Pages